Industry collaboration, scientific sharing, and the dissemination of knowledge

Social Studies of Science

Volumn 40, Issue 5, 2010, Pages 757-791

  Evans, James A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

industry collaboration; science policy; secrecy; sharing; sociology of science

Indexed keywords

EID: 77957234836     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312710379931     Document Type: Article

References (96)

1. Adams, James D. (2001) Comparative Localization of Academic and Industrial Spillovers, NBER Working Paper 7843 (Cambridge, MA: National Bureau of Economic Research).
2. Adams, James D. & Adam B. Jaffe (1996) 'Bounding the Effects of R&D: An Investigation Using Matched Establishment-firm Data', NBER Working Paper 5544 (Cambridge, MA: National Bureau of Economic Research).
3. Ankeny, Rachel (2007) Wormy Logic: Model Organisms as Case-based Reasoning, in A.N.H. Creager, E. Lunbeck & M.N. Wise (eds), Science Without Laws: Model Systems, Cases, Exemplary Narratives (Durham, NC: Duke University Press): 46-58.
4. Arrow, Kenneth J. (1962) Economic Welfare and the Allocation of Resources for Inventions, in Richard R. Nelson (ed.), The Rate and Direction of Inventive Activity: Economic and Social Factors (Princeton, NJ: Princeton University Press).
5. Azoulay, Pierre, Waverly Ding & Toby Stuart (2006) 'The Impact of Academic Patenting on the Rate, Quality and Direction of (Public) Research Output', NBER Working Paper 11917 (Cambridge, MA: National Bureau of Economic Research).
6. Bekelman, J.E., Y. Li & C.P. Gross (2003) Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review, Journal of the American Medical Association 289(4): 454-65.
7. Berman, Elizabeth Popp (2008) Why Did Universities Start Patenting? Institution-building and the Road to the Bayh-Dole Act, Social Studies of Science 38(6): 835-71.
8. Blumenthal, David, Eric G. Campbell, Nanyanne Causino & Karen S. Louis (1996) Participation of Life-science Faculty in Research Relationships with Industry, New England Journal of Medicine 355: 1734-39.
9. Buttel, Frederick H. & Jill Belsky (1987) Biotechnology, Plant Breeding, and Intellectual Property: Social and Ethical Dimensions, Science, Technology, & Human Values 12(1): 31-49.
10. Calvert, Jane (2006) What's Special about Basic Research?, Science Technology, & Human Values 31(2): 199-220.
11. Cambrosio, Alberto, Peter Keating & Andrei Mogoutov (2004) Mapping Collaborative Work and Innovation in Bioscience, Social Studies of Science 34(3): 325-64.
12. Campbell, Eric G., B.R. Clarridge, M. Gokhale, L. Birenbaum, S. Hilgartner, N.A. Holtzman & David Blumenthal (2002) Data Withholding in Academic Genetics: Evidence from a National Survey, Journal of the American Medical Association 287(4): 473-80.
13. Chang, Jeffrey, Hinrich Schutz & Russ Altman (2004) GAPSCORE: Finding Gene and Protein Names One Word at a Time, Bioinformatics 20(2): 216-25.
14. Charles, Daniel (2001) Lords of the Harvest: Biotech, Big Money, and the Future of Food (Cambridge, MA: Perseus Publishing).
15. Cho, M.K. & L.A. Bero (1996) The Quality of Drug Studies Published in Symposium Proceedings, Annals of Internal Medicine 124(5): 485-89.
16. Clifford, Tammy J., Nicholas Barrowman & David Moher (2002) Funding Source, Trial Outcome and Reporting Quality: Are They Related? Results of a Pilot Study, BMC Health Services Research 2(18): 1-6.
17. Cohen, Wesley M., Richard R. Nelson & John P. Walsh (2000) Protecting their Intelletual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not), NBER Working Paper 7552 (Cambridge, MA: National Bureau of Economic Research).
18. Collins, H.M. (1974) The Tea Set: Tacit Knowledge and Scientific Networks, Science Studies 4(2): 165-85.
19. Collins, H.M. (1985) Changing Order: Replication and Induction in Scientific Practice (London & Beverly Hills: Sage Publications).
20. Dasgupta, Partha & Paul A. David (1994) Toward a New Economics of Science, Research Policy 23: 487-521.
21. David, Paul A. (2004) From Keeping Nature's Secrets to the Institutionalization of Open Science, Working Paper no. 04-006. Available at: www.-econ.stanford.edu/faculty/workp/swp04006.pdf (accessed 29 June 2010).
22. Davidson, R.A. (1986) Source of Funding and Outcome of Clinical Trials, Journal of General Internal Medicine 1(3): 155-58.
23. Dickersin, K., Y.I. Min & C.L. Meinert (1992) Factors Influencing Publication of Research Results. Follow-up of Applications Submitted to Two Institutional Review Boards, JAMA 267(3): 374-78.
24. Djulbegovic, B., C.L. Bennet & G.H. Lyman (1999) Violation of the Uncertainty Principle in the Conduct of Randomized Controlled Trials (RCTs) of Erythropoietin (EPO), Blood 94(supplement 1): 399A.
25. Easterbrook, P.J., J.A. Berlin, R. Gopalan & D.R. Matthews (1991) Publication Bias in Clinical Research, Lancet 337(8746): 867-72.
26. Evans, James A. (2010) Industry Induces Academic Science to Know Less About More, American Journal of Sociology 116(2) (in press).
27. Faberge, A.C. (1982) Open Information and Secrecy in Research, Perspectives in Biology and Medicine 25: 263-78.
28. Godin, Benoit (2006) The Linear Model of Innovation: The Historical Construction of an Analytical Framework, Science, Technology, & Human Values 31(6): 639-67.
29. Grandin, Karl, Nina Wormbs & Sven Widmalm (2004) The Science-Industry Nexus: History, Policy, Implications: Nobel Symposium 123 (Sagamore Beach, MA: Science History Publications/USA).
30. Hackett, Edward J. (2005) Essential Tensions: Identity, Control and Risk in Research, Social Studies of Science 35(5): 787-826.
31. Heller, Michael A. & Rebecca S. Eisenberg (1998) Can Patents Deter Innovation? The Anticommons in Biomedical Research, Science 280: 698.
32. Hernán, Miguel A., Babetter Brumback & James M. Robins (2001) Marginal Structural Models to Estimate the Joint Causal Effect of Nonrandomized Treatments, Journal of the American Statistical Association 96(454): 440-48.
33. Hine, Christine (2006) Databases as Scientific Instruments and Their Role in the Ordering of Scientific Work, Social Studies of Science 36(2): 269-98.
34. Jadad, A.R., M. Moher, G.P. Browman, L. Booker, C. Sigouin, M. Fuentes & R. Stevens (2000) Systematic Reviews and Meta-analyses on Treatment of Asthma: Critical Evaluation, BMJ 320(7234): 537-40.
35. Jaffe, A.B., M. Trajtenberg & R. Henderson (1993) Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations, Quarterly Journal of Economics 108(3): 577-98.
36. Kaiser, David (2002) Cold War Requisitions, Scientific Manpower, and the Production of American Physicists after World War II, Historical Studies in the Physical and Biological Sciences 33: 131-59.
37. Kevles, Daniel J. (1978) The Physicists: The History of a Scientific Community in Modern America (New York: Knopf).
38. Kjaergard, L.L., D. Nikolova & C. Gluud (1999) Randomized Clinical Trials in Hepatology: Predictors of Quality, Hepatology 30(5): 1134-38.
39. Kleinman, Daniel Lee (1998) Pervasive Influence: Intellectual Property, Industrial History, and University Science, Science and Public Policy 25(2): 95-102.
40. Kleinman, Daniel Lee & Mark Solovey (1995) Hot Science/Cold War: The National Science Foundation after World War II, Radical History Review 63: 110-33.
41. Knorr-Cetina, Karin (1999) Epistemic Cultures: How the Sciences Make Knowledge (Cambridge, MA: Harvard University Press).
42. Knox, K.S., J.R. Adams, B. Djulbegovic, T.J. Stinson, C. Tomor & C.L. Bennet (2000) Reporting and Dissemination of Industry Versus Non-profit Sponsored Economic Analyses of Six Novel Drugs Used in Oncology, Annals of Oncology 11(12): 1591-95.
43. Kohler, Robert E. (1994) Lords of the Fly: Drosophila Genetics and the Experimental Life (Chicago: University of Chicago Press).
44. Latour, Bruno (1987) Science in Action: How to Follow Scientists and Engineers through Society (Cambridge, MA: Harvard University Press).
45. Latour, Bruno & Steve Woolgar (1979) Laboratory Life: The Social Construction of Scientific Facts (London & Beverly Hills: Sage).
46. Leslie, Stuart W. (1993) The Cold War and American Science: The Military-Industrial-Academic Complex at MIT and Stanford (New York: Columbia University Press).
47. Lexchin, J., L.A. Bero, B. Djulbegovic & O. Clark (2003) Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review, BMJ 326(7400): 1167-70.
48. Liebeskind, Julia Porter (2000) Property Rights, Secrecy, and the Boundaries of the Firm: Theory and Evidence, USC Marshall School of Business Working Paper (Los Angeles: University of Southern California).
49. Lolle, S.J., J.L. Victor, J.M. Young & R.E. Pruitt (2005) Genome-wide Non-Mendelian Inheritance of Extra-Genomic Information in Arabidopsis, Nature 434(7032): 505-09.
50. Mandelkern, M. (1999) Manufacturer Support and Outcome, Journal of Clinical Psychiatry 60(2): 122-23.
51. Marshall, E. (2002) Data Sharing. DNA Sequencer Protests Being Scooped With His Own Data, Science 295(5558): 1206-07.
52. Masco, Joseph (2006) The Nuclear Borderlands: The Manhattan Project in Post-Cold War New Mexico (Princeton, NJ: Princeton University Press).
53. Massie, B.M. & D. Rothenberg (1993) Publication of Sponsored Symposiums in Medical Journals, New England Journal of Medicine 328(16): 1196-97; author reply97-98.
54. McCain, Katherine W. (1991) Communication, Competition, and Secrecy: The Production and Dissemination of Research-Related Information in Genetics, Science, Technology, & Human Values 16(4): 491-516.
55. Mello, M.M., B.R. Clarridge & D.M. Studdert (2005) Academic Medical Centers' Standards for Clinical-trial Agreements with Industry, New England Journal of Medicine 352(21): 2202-10.
56. Merrill, S.A. & R.S. Cooper (1999) Trends in Industrial Research and Development: Evidence from National Data Sources, in National Research Council Board on Science, Technology and Economic Policy, Securing America's Industrial Strength (Washington, DC: National Academy Press): 99-116.
57. Merton, Robert K. (1942) Science and Technology in a Democratic Order, Journal of Legal and Political Sociology 1: 115-26.
58. Merton, Robert K. (1957) Priorities in Scientific Discovery: A Chapter in the Sociology of Science, American Sociological Review 22: 635-59.
59. Merton, Robert King (1976) The Ambivalence of Scientists, in R.K. Merton (ed.), Sociological Ambivalence and Other Essays (New York: Free Press): 32-65.
60. Meyerowitz, Elliot M. (2001) Prehistory and History of Arabidopsis Research, Plant Physiology 125: 15-19.
61. Mitroff, Ian I. (1974) Norms and Counter-norms in a Select Group of Apollo Moon Scientists: Case Study of Ambivalence of Scientists, American Sociological Review 39(4): 579-95.
62. Mowery, David C. (1999) America's Industrial Resurgence? An Overview, in National Research Council, U.S. Industry in 2000: Studies in Competitive Performance (Washington, DC: National Academy Press): 1-16.
63. Mulkay, Michael J. (1976) Norms and Ideology in Science, Social Science Information 15(4/5): 637-56.
64. Mulkay, Michael J. & David O. Edge (1973) Social, Cognitive and Technical Factors in the Growth of Radio Astronomy, Social Science Information 12(6): 36.
65. Murray, Fiona & Scott Stern (2005) Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-commons Hypothesis, NBER Working Paper 11465 (Cambridge, MA: National Bureau of Economic Research). Available at www.nber.org/papers/w11465 (accessed 27 March 2010).
66. Neumann, P.J., E.A. Sandberg, C.M. Bell, P.W. Stone & R.H. Chapman (2000) Are Pharmaceuticals Cost-effective? A Review of the Evidence, Health Affairs (Millwood) 19(2): 92-109.
67. Nottenburg, Carol, Philip G. Pardey & Brian D. Wright (2001) 'Accessing Other People's Technologies: Do Non-profit Research Agencies Need It? How to Obtain It', EPTD Discussion Paper No. 79 (Washington, DC: International Food Policy Research Institute).
68. Polanyi, Michael (1962) The Republic of Science: Its Political and Economic Theory, Minerva 1: 54-74.
69. Powell, Walter W. (1990) Neither Market Nor Hierarchy: Network Forms of Organization, Research in Organizational Behavior 12: 295-336.
70. Powell, Walter W. (1996) Interorganizational Collaboration in the Biotechnology Industry, Journal of Institutional and Theoretical Economics 120: 197-215.
71. Press, Eyal & Jennifer Washburn (2000) The Kept University, Atlantic Monthly 285: 39-54.
72. Rader, Karen A. (2004) Making Mice: Standardizing Animals for American Biomedical Research, 1900-1955 (Princeton: Princeton University Press).
73. Relman, Arnold S. (1980) The New Medical-Industrial Complex, New England Journal of Medicine 303(17): 963-70.
74. Relman, Arnold S. (1984) Dealing with Conflict of Interest, New England Journal of Medicine 310(18): 1182-83.
75. Remington, John A. (1988) Beyond Big Science in America: The Binding of Inquiry, Social Studies of Science 18: 45-72.
76. Robins, J.M., M.A. Hernán & B. Brumback (2000) Marginal Structural Models and Causal Inference in Epidemiology, Epidemiology 11: 550-60.
77. Rochon, P.A., J.H. Gurwitz, C.M. Cheung, J.A. Hayes & T.C. Chalmers (1994) Evaluating the Quality of Articles Published in Journal Supplements Compared with the Quality of those Published in the Parent Journal, Journal of the American Medical Association 272(2): 108-13.
78. Rosenberg, Nathan (1982) The Growing Role of Science in the Innovation Process, in C.G. Bernhard, E.C. and P. Sorbom (eds), Science, Technology and Society in the Time of Alfred Nobel (Oxford: Pergamon Press): 231-46.
79. Sahlins, Marshall David (1972) Stone Age Economics (Chicago: Aldine-Atherton).
80. Sapolsky, Harvey M. (1990) Science and the Navy: The History of the Office of Naval Research (Princeton, NJ: Princeton University Press).
81. Shapin, Steven (1994) A Social History of Truth: Civility and Science in Seventeenth-century England (Chicago: University of Chicago Press).
82. Shapin, Steven (2008) The Scientific Life: A Moral History of a Late Modern Vocation (Chicago: University of Chicago Press).
83. Sismondo, Sergio (2008) Pharmaceutical Company Funding and its Consequences: A Qualitative Systematic Review, Contemporary Clinical Trials 29 (2): 109-13.
84. Somerville, Chris (2001) An Early Arabidopsis Demonstration. Resolving a Few Issues Concerning Photorespiration, Plant Physiology 125(1): 20-24.
85. Somerville, Chris & Maarten Koornneef (2002) A Fortunate Choice: The History of Arabidopsis as a Model Plant, Nature Reviews Genetics 3(11): 883-89.
86. Sorenson, Olav & Lee Fleming (2004) Science and the Diffusion of Knowledge, Research Policy 33(10): 1615-34.
87. Sorenson, Olav & Toby Stuart (2001) Syndication Networks and the Spatial Distribution of Venture Capital Investments, American Journal of Sociology 106: 1546-88.
88. Stelfox, H.T., G. Chua, K. O'Rourke & A.S. Detsky (1998) Conflict of Interest in the Debate over Calcium-channel Antagonists, New England Journal of Medicine 338(2): 101-06.
89. Stern, J.M. & R.J. Simes (1997) Publication Bias: Evidence of Delayed Publication in a Cohort Study of Clinical Research Projects, BMJ 315(7109): 640-45.
90. Vandenbroucke, J.P., F.M. Helmerhorst & F.R. Rosendaal (2000) Competing Interests and Controversy about Third Generation Oral Contraceptives. BMJ Readers Should Know Whose Words They Read, BMJ 320(7231): 381-82.
91. Wahlbeck, K. & C. Adams (1999) Beyond Conflict of Interest. Sponsored Drug Trials Show More-favourable Outcomes, BMJ 318(7181): 465.
92. Walbot, V. (2000) Arabidopsis Thaliana Genome. A Green Chapter in the Book of Life, Nature 408(6814): 794-95.
93. Washburn, Jennifer (2005) University, Inc.: The Corporate Corruption of American Higher Education (New York: Basic Books).
94. Watson, James D. (1968) The Double Helix: A Personal Account of the Discovery of the Structure of DNA (London: Weidenfeld & Nicolson).
95. Westfall, Richard S. (1980) Never at Rest: A Biography of Isaac Newton (Cambridge & New York: Cambridge University Press).
96. Yaphe, J., R. Edman, B. Knishkowy & J. Herman (2001) The Association between Funding by Commercial Interests and Study Outcome in Randomized Controlled Drug Trials, Family Practice 18(6): 565-68.